← FDA Drug Approvals (Drugs@FDA)

AZACITIDINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RELIANCE LIFE · Approved 2025-05-20

Drug application

FDA Application #
ANDA217453
Application type
Abbreviated New Drug Application (Generic)
Brand name
AZACITIDINE
Generic name
AZACITIDINE
Active ingredients
AZACITIDINE
Dosage form
POWDER
Route
INTRAVENOUS, SUBCUTANEOUS
Marketing status
Prescription
Sponsor
RELIANCE LIFE
Manufacturer
Reliance Life Sciences Private Limited
First approval
2025-05-20

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown